- AMD +3.02%
Search results
- 150.58Add to watchlist+4.42 (+3.02%)At close: Fri. May 3, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open148.82High150.79Low147.25
- Mkt Cap243.38BP/E (TTM)218.23Div & YieldN/A & N/A
- Prev. Close146.1652 Wk. Low89.1752 Wk. High227.30
What analysts are sayingTop storiesWhy AMD (AMD) Stock Is Trading Lower TodayYahoo Finance · 4 days agoShould Investors Buy the Dip in AMD (AMD) or Super Micro Computer's (SMCI) Stock After Earnings?Yahoo Finance · 3 days ago- AMD +3.02%
AMD (AMD) To Report Earnings Tomorrow: Here Is What To ExpectYahoo Finance · 7 days agoRelated stocks
We would like to show you a description here but the site won’t allow us.
See Advanced Micro Devices, Inc. (AMD) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Mar 4, 2024 · Apr 30, 2024 • 5:00 pm EDT. Mar 5, 2024 • 8:00 am PDT. Feb 20, 2024 • 10:00 am PDT. View Presentation. For 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies for gaming, immersive platforms and the datacenter.
AMD is the only processor manufacturer that has committed to years of future support for the cutting-edge Socket AM5 platform, so you will be able to upgrade to new processors we haven’t even announced yet. The newest AMD desktop platform is packed with state-of-the-art technologies including high-speed DDR5 memory, ...
Jan 1, 2023 · In the AMD prediction studies carried out with different lithologies of Çan coal basin (NW Turkey), pyrite has been determined as the main acid producer, and therefore the strong acid production capacity in the absence of carbonate-group minerals has been determined in the lithologies including coal mine tailings, and altered volcanic and ...
Priscila Pereira ... sound editor (20 episodes, 2021-2023) Juliano Schultz ... foley artist (20 episodes, 2021-2023) Brunna Midori Arruda
Phosphate-binder therapy for hyperphosphataemia is key to the treatment of patients with chronic kidney disease (CKD)-mineral and bone disorder (MBD). Calcium-free phosphate binders are increasingly favoured since calcium-based agents potentially cause harmful calcium overload and vascular calcification that confound the benefits of reducing ...